Literature DB >> 28494925

Comparison of humoral and T-cell-mediated immune responses to a single dose of Bovela® live double deleted BVDV vaccine or to a field BVDV strain.

Ratree Platt1, Lyle Kesl2, Christian Guidarini3, Chong Wang1, James A Roth4.   

Abstract

The objective of this study was to determine and compare the humoral and cellular immune responses of calves exposed to a single dose of Bovela® bovine viral diarrhea virus (BVDV) live double deleted vaccine or a field strain virus (FSV) of BVDV type 2 (strain 890). Thirty seronegative, colostrum-deprived 5 month-old Holstein steer calves that tested negative for persistent BVDV by ear notch immunohistochemistry and seronegative to BVDV types 1 and 2 were used. Calves were screened by multi-parameter flow cytometry (MP-FCM) 1 week before vaccination to ensure that they were negative for T cell responses to the BVDV types 1 and 2 viruses in the Bovela® vaccine. Calves were assigned to 3 treatment groups: control (PBS), FSV inoculated, and Bovela® vaccinated. The humoral response was tested by standard serum virus neutralization (SVN) test to BVDV types 1 (Singer strain) and 2 (strain 125). The response by CD4, CD8, and gamma delta (γδ TCR) T cells was evaluated by MP-FCM using individual BVDV types 1 and 2 from Bovela® vaccine as recall antigens at 5, 6, and 7 weeks after vaccination. Activation markers used were upregulation of surface CD25 (IL-2R), intracellular interferon gamma (IFNγ) and intracellular interleukin 4 (IL-4). Each T cell subset was evaluated for increased expression of each activation marker compared to non-antigen stimulated cells of the same animal. All Bovela® vaccinated and FSV inoculated calves produced SVN antibodies to both BVDV types 1 and 2 while control animals remained seronegative throughout the study. The mean (weeks 5, 6, and 7) T cell recall responses to Bovela® BVDV type 1 and type 2 recall antigens were numerically higher in all three T cell subsets (CD4, CD8, and γδ TCR) for all three activation markers (CD25, IFNγ, and IL-4) when compared to either the control animals or to the FSV inoculated animals. These differences were often, but not always, statistically significant (P<0.05).
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28494925     DOI: 10.1016/j.vetimm.2017.03.003

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  8 in total

Review 1.  Recent Advances on the Bovine Viral Diarrhea Virus Molecular Pathogenesis, Immune Response, and Vaccines Development.

Authors:  Anwar A G Al-Kubati; Jamal Hussen; Mahmoud Kandeel; Abdullah I A Al-Mubarak; Maged Gomaa Hemida
Journal:  Front Vet Sci       Date:  2021-05-14

2.  Selection and characterization of specific nanobody against bovine virus diarrhea virus (BVDV) E2 protein.

Authors:  Tiansen Li; Meiling Huang; Hongran Xiao; Guoqi Zhang; Jinhua Ding; Peng Wu; Hui Zhang; Jinliang Sheng; Chuangfu Chen
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

Review 3.  Control of Bovine Viral Diarrhea.

Authors:  Volker Moennig; Paul Becher
Journal:  Pathogens       Date:  2018-03-08

4.  Mosaic Bovine Viral Diarrhea Virus Antigens Elicit Cross-Protective Immunity in Calves.

Authors:  Neha Sangewar; Wisam Hassan; Shehnaz Lokhandwala; Jocelyn Bray; Rachel Reith; Mary Markland; Huldah Sang; Jianxiu Yao; Bailey Fritz; Suryakant D Waghela; Karim W Abdelsalam; Christopher C L Chase; Waithaka Mwangi
Journal:  Front Immunol       Date:  2020-11-12       Impact factor: 7.561

5.  Development of an advanced flow cytometry based high-resolution immunophenotyping method to benchmark early immune response in dairy cows.

Authors:  Sabine Farschtschi; Martin Mattes; Alex Hildebrandt; Dapi Chiang; Benedikt Kirchner; Heike Kliem; Michael W Pfaffl
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

6.  Co-administration of a plasmid encoding CD40 or CD63 enhances the immune responses to a DNA vaccine against bovine viral diarrhea virus in mice.

Authors:  Dongze Leng; Shinji Yamada; Yusuke Chiba; Syuji Yoneyama; Yusuke Sakai; Hirokazu Hikono; Kenji Murakami
Journal:  J Vet Med Sci       Date:  2022-07-07       Impact factor: 1.105

Review 7.  The Irish Programme to Eradicate Bovine Viral Diarrhoea Virus-Organization, Challenges, and Progress.

Authors:  David Graham; Simon J More; Padraig O'Sullivan; Elizabeth Lane; Damien Barrett; Jose-Maria Lozano; Hans-Hermann Thulke; Sharon Verner; Maria Guelbenzu
Journal:  Front Vet Sci       Date:  2021-06-01

8.  Deciphering the Role of Bovine Viral Diarrhea Virus Non-Structural NS4B Protein in Viral Pathogenesis.

Authors:  Shahbaz Bashir; Andrey Kossarev; Violeta Cascon Martin; Jan Paeshuyse
Journal:  Vet Sci       Date:  2020-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.